Advertisement

Substance Use Disorders

  • David S. Levitt
  • Jared W. KleinEmail author
Chapter

Abstract

Substance use disorders are common and associated with increased perioperative risk. The perioperative period offers a unique opportunity to engage patients in addiction treatment. Whenever possible, clinicians should assess for substance use preoperatively, create a plan to manage withdrawal symptoms during the perioperative period and initiate or refer for treatment when patients are amenable.

Keywords

Substance use disorder Addiction Tobacco Alcohol Opioids 

Notes

Acknowledgments

Dr. Ashok Reddy authored a prior version of this chapter. Dr. Avital O’Glasser and Dr. Honora Englander generously shared their comprehensive list of references with the authors.

References

  1. 1.
    Bauer UE, Briss PA, Goodman RA, Bowman BA. Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 2014;384(9937):45–52.CrossRefGoogle Scholar
  2. 2.
    Spies C, Tonnesen H, Andreasson S, Helander A, Conigrave K. Perioperative morbidity and mortality in chronic alcoholic patients. Alcohol Clin Exp Res. 2001. Suppl;25(5):164S–70S.CrossRefGoogle Scholar
  3. 3.
    Grønkjær M, Eliasen M, Skov-Ettrup LS, et al. Preoperative smoking status and postoperative complications: a systematic review and meta-analysis. Ann Surg. 2014;259(1):52–71.CrossRefGoogle Scholar
  4. 4.
    Sørensen LT. Wound healing and infection in surgery: the pathophysiological impact of smoking, smoking cessation, and nicotine replacement therapy: a systematic review. Ann Surg. 2012 Jun;255(6):1069–79.CrossRefGoogle Scholar
  5. 5.
    Tonnesen H, Kehlet H. Preoperative alcoholism and postoperative mortality. Br J Surg. 1999;86(7):869–874. Open image in new windowGoogle Scholar
  6. 6.
    Hedegaard H, Warner M, Miniño AM. Drug overdose deaths in the United States, 1999–2016. NCHS Data Brief, no 294. Hyattsville, MD: National Center for Health Statistics. 2017/ CDC. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2016. Available at http://wonder.cdc.gov. Accessed 4/5/2018.
  7. 7.
    Brummett CM, Waljee FJ, Goesling J, et al. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017;152(6):e170504.CrossRefGoogle Scholar
  8. 8.
    Van Boekel LC, Brouwers EPM, van Weeghel J, et al. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alc Depend. 2013;131(1–2):23–35.CrossRefGoogle Scholar
  9. 9.
    Geppert CM, Bogenschutz MP. Ethics in substance use disorder treatment. Psychiatr Clin North Am. 2009;32(2):283–97.CrossRefGoogle Scholar
  10. 10.
    Velez CM, Nicolaidis C, Korthuis PT, et al. It’s been an experience, a life learning experience’: a qualitative study of hospitalized patients with substance use disorders. J Gen Intern Med. 2017 Mar;32(3):296–303.CrossRefGoogle Scholar
  11. 11.
    Botticelli MP, Koh HK. Changing the language of addiction. JAMA. 2016;316(13):1361–2.CrossRefGoogle Scholar
  12. 12.
    Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010 May;21(3):202–7.CrossRefGoogle Scholar
  13. 13.
    Van Boekel LC, Brouwers EP, van Weeghel J, et al. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend 2013;131(1–2):23–35. Open image in new windowGoogle Scholar
  14. 14.
    Smith PC, Schmidt SM, Allensworth-Davies D, et al. A single-question screening test for drug use in primary care. Arch Intern Med. 2010;170(13):1155–60.CrossRefGoogle Scholar
  15. 15.
    Wakeman SE, Metlay JP, Chang Y, et al. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909–16.CrossRefGoogle Scholar
  16. 16.
    Nolan MB, Warner DO. Safety and efficacy of nicotine replacement therapy in the perioperative period: a narrative review. Mayo Clin Proc. 2015;90(11):1553–1561. Open image in new windowGoogle Scholar
  17. 17.
    Reuther WJ, Brennan PA. Is nicotine still the bad guy? Summary of the effects of smoking on patients with head and neck cancer in the postoperative period and the uses of nicotine replacement therapy in these patients. Br J Oral Maxillofac Surg. 2014;52(2):102–5.CrossRefGoogle Scholar
  18. 18.
    Warner MA, Offord KP, Warner ME, et al. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc. 1989;64(6):609–16.CrossRefGoogle Scholar
  19. 19.
    Myers K, Hajek P, Hinds C, et al. Stopping smoking shortly before surgery and postoperative complications: a systematic review and meta-analysis. Arch Intern Med. 2011;171(11):983–9.CrossRefGoogle Scholar
  20. 20.
    Wong J, Lam DP, Abrishami A, et al. Short-term preoperative smoking cessation and postoperative complications: a systematic review and meta-analysis. Can J Anaesth. 2012;59(3):268–79.CrossRefGoogle Scholar
  21. 21.
    Wong J, Abrishami A, Yang Y, et al. A perioperative smoking cessation intervention with varenicline: a double-blind, randomized, placebo-controlled trial. Anesthesiology. 2012;117(4):755–64.CrossRefGoogle Scholar
  22. 22.
    Bradley KA, Rubinsky AD, Sun H, et al. Alcohol screening and risk of postoperative complications in male VA patients undergoing major non-cardiac surgery. J Gen Intern Med. 2011;26(2):162–9.CrossRefGoogle Scholar
  23. 23.
    Rubinsky AD, Sun H, Blough DK, et al. AUDIT-C alcohol screening results and postoperative inpatient health care use. J Am Coll Surg. 2012;214(3):296–305.CrossRefGoogle Scholar
  24. 24.
    Tonnesen H, Rosenberg J, Nielsen HJ, et al. Effect of preoperative abstinence on poor postoperative outcome in alcohol misusers: randomised controlled trial. BMJ. 1999;318(7194):1311–6.CrossRefGoogle Scholar
  25. 25.
    Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA. 1994;272(7):519–23.CrossRefGoogle Scholar
  26. 26.
    Hendey GW, Dery RA, Barnes RL, et al. A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal. Am J Emerg Med. 2011;29(4):382–5.CrossRefGoogle Scholar
  27. 27.
    Marschall KE, Hines RL. Chapter 29: Psychiatric disease, substance abuse and drug overdose. In: Hines R, Marschall K, editors. Stoelting’s anesthesia and co-existing disease. 7th ed. Philadelphia: Elsevier; 2018. p. 611–33.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Department of Medicine, Division of General Internal MedicineUniversity of WashingtonSeattleUSA

Personalised recommendations